145 related articles for article (PubMed ID: 7510220)
1. Role of prostate specific antigen (PSA) and carcinoembryonic antigen (CEA) in screening for prostate and recurrent colon cancers in the elderly.
Vandenberg TA
Clin Biochem; 1993 Dec; 26(6):429-30. PubMed ID: 7510220
[No Abstract] [Full Text] [Related]
2. Serum mucin antigens CASA and MSA in tumors of the breast, ovary, lung, pancreas, bladder, colon, and prostate. A blind trial with 420 patients.
Devine PL; McGuckin MA; Ramm LE; Ward BG; Pee D; Long S
Cancer; 1993 Sep; 72(6):2007-15. PubMed ID: 7689923
[TBL] [Abstract][Full Text] [Related]
3. Relapsed prostate cancer with neuroendocrine differentiation and high serum levels of carcinoembryonic antigen without elevation of prostrate-specific antigen: a case report.
Kinebuchi Y; Noguchi W; Irie K; Nakayama T; Kato H; Nishizawa O
Int J Urol; 2007 Feb; 14(2):147-9. PubMed ID: 17302572
[TBL] [Abstract][Full Text] [Related]
4. Monitoring of Serum Carcinoembryonic Antigen Levels after Curative Resection of Colon Cancer: Cutoff Values Determined according to Preoperative Levels Enhance the Diagnostic Accuracy for Recurrence.
Saito G; Sadahiro S; Kamata H; Miyakita H; Okada K; Tanaka A; Suzuki T
Oncology; 2017; 92(5):276-282. PubMed ID: 28178692
[TBL] [Abstract][Full Text] [Related]
5. Markers of undiagnosed incidental cancer in comparison with clinical prostatic cancer.
Ogawa A; Yoshida A; Kanda T; Sugihara S; Suzuki T; Tamura J; Kobayashi I; Nakazato Y
J Med; 2000; 31(1-2):101-10. PubMed ID: 10998759
[TBL] [Abstract][Full Text] [Related]
6. [Recrudescence of prostate cancer with low serum level of PSA and high serum level of CEA and CA19-9: a case report].
Yokoyama S; Fukuhara S; Imazu T; Hara T; Yamaguchi S; Adachi S
Hinyokika Kiyo; 2007 Jul; 53(7):485-7. PubMed ID: 17702183
[TBL] [Abstract][Full Text] [Related]
7. Multiple tumor marker elevation in androgen ablation-refractory prostate cancer with long-term response to metronomic chemotherapy: a case report.
Massaccesi M; Forni F; Spagnuolo P; Macchia G; Mignogna S; De Ninno M; Cellini N; Giardina B; Carbone A; Morganti AG
Int J Biol Markers; 2010; 25(4):243-7. PubMed ID: 21161947
[TBL] [Abstract][Full Text] [Related]
8. PSA and the detection of prostate cancer.
Robbins AS
JAMA; 1994 Jan; 271(3):192-3. PubMed ID: 7506314
[No Abstract] [Full Text] [Related]
9. CEA for monitoring colon cancer.
Chu DZ; Ellenhorn JD; Paz IB; Wagman LD; Williams WL
JAMA; 1994 Feb; 271(5):345-6; author reply 346-7. PubMed ID: 8283579
[No Abstract] [Full Text] [Related]
10. Relation between Carcinoembryonic Antigen Levels in Colon Cancer Tissue and Serum Carcinoembryonic Antigen Levels at Initial Surgery and Recurrence.
Saito G; Sadahiro S; Okada K; Tanaka A; Suzuki T; Kamijo A
Oncology; 2016; 91(2):85-9. PubMed ID: 27260164
[TBL] [Abstract][Full Text] [Related]
11. The use of serum tumor markers in the management of patients with malignancy.
Markman M
J Cancer Res Clin Oncol; 1993; 119(11):635-6. PubMed ID: 7688748
[No Abstract] [Full Text] [Related]
12. Prostate cancer: estimating the benefits of PSA screening.
Vickers AJ; Lilja H
Nat Rev Urol; 2009 Jun; 6(6):301-3. PubMed ID: 19498406
[TBL] [Abstract][Full Text] [Related]
13. CEA for monitoring colon cancer.
Cohen AM; Paty P
JAMA; 1994 Feb; 271(5):346; author reply 346-7. PubMed ID: 8283580
[No Abstract] [Full Text] [Related]
14. CEA for monitoring colon cancer.
Corman M; Prager ED
JAMA; 1994 Feb; 271(5):346; author reply 346-7. PubMed ID: 8283581
[No Abstract] [Full Text] [Related]
15. Distributions in CEA doubling time differ in patients with recurrent colorectal carcinomas.
Yamamoto M; Maehara Y; Sakaguchi Y; Mine H; Yamanaka T; Korenaga D; Okamura T
Hepatogastroenterology; 2004; 51(55):147-51. PubMed ID: 15011851
[TBL] [Abstract][Full Text] [Related]
16. [Prostate cancer screening: no proof of the benefit].
Laplanche A; Hill C
Presse Med; 2009 Oct; 38(10):1393-5. PubMed ID: 19647979
[No Abstract] [Full Text] [Related]
17. Serial measurements of tissue polypeptide specific antigen (TPS), PSA, PAP and CEA serotest values in treated patients with primary and metastatic prostate cancer.
Tarle M
Anticancer Res; 1993; 13(3):769-77. PubMed ID: 7686362
[TBL] [Abstract][Full Text] [Related]
18. [Recrudescent prostate cancer with a low serum PSA level and a high serum CEA level treated with docetaxel : a case report].
Fujita M; Goto T; Uchida K; Saiki S; Arima R
Hinyokika Kiyo; 2013 Mar; 59(3):183-8. PubMed ID: 23633635
[TBL] [Abstract][Full Text] [Related]
19. Early-stage prostate cancer, PSA screening rates decline.
Printz C
Cancer; 2016 Mar; 122(6):825. PubMed ID: 26938268
[No Abstract] [Full Text] [Related]
20. [Elevated PSA--what to do?].
Machemer H; Rohde D
MMW Fortschr Med; 2008 Oct; 150(44):38-9. PubMed ID: 19024490
[No Abstract] [Full Text] [Related]
[Next] [New Search]
